ORTEXORTEX News
Tracking NAVI? Get live short interest, options flow, and signals on ORTEX.Sign up free →
NA
Trader NoteNAVI

Navient heads into earnings with an activist on the register and shorts still elevated

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 21 Oct 2026, 22:31

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

NAVI enters its October 28 quarterly print carrying a tension that has defined the stock for most of 2026: a large activist stake locked in at the top of the register, short interest running near 12% of the free float, and a share price that has given up more than 5% over the past month to close at $8.98.

The positioning picture is one of entrenched bearishness rather than a building squeeze. Short interest of roughly 11.5 million shares amounts to 11.8% of the free float, up about 0.7% over the past week though still below the early-October peak of around 12.2 million shares. The borrow market is relaxed: cost to borrow is just 0.52%, barely changed in recent weeks, and availability is running at 364%, meaning there are roughly 3.6 shares available to lend for every one already shorted. That is well above the 52-week low of 198% reached earlier in the year. Shorts are present in size, but there is no evidence of a crowded, expensive trade or any squeeze dynamic. Options tell a similar story: the put/call ratio at 1.58 is above its 20-day average of 1.53, though only a third of a standard deviation above the mean, not an extreme read. The ORTEX short score of 68.4 has been drifting lower over the past week from around 69.5, which moderately reduces the short-side pressure signal.

The Street is broadly cautious, with no bulls visible among the active coverage names. JP Morgan raised its target to $8.50 from $8.00 on October 12, keeping a Neutral rating, while Barclays cut to $7.00 from $8.00 just a week earlier, maintaining its Underweight call. TD Cowen carries a Sell with an $8.50 target, and Morgan Stanley holds Equal-Weight at $9.00. The mean target of $9.00 sits barely above the current price, suggesting the Street sees the stock as close to fairly valued at best. The valuation tells a different story on book: price-to-book at 0.33 is deeply cheap, and the earnings yield ranks in the 88th percentile on EPS surprise. EPS momentum over 30 and 90 days scores in the 90th and 91st percentiles respectively. The bull case from the company's own positioning in higher-quality graduate ABS paper, and strong investor demand at June's ABS sale, runs into the bear case of deteriorating consumer NIM (down 44 basis points to 2.32%) and rising net charge-offs, with revenue estimates having been revised down across the board.

The single most structurally important fact about NAVI's ownership is that Sherborne Investors Management LP has filed a Schedule 13D on the stock, making it a confirmed activist situation. Sherborne last amended its filing in April 2026, reporting a 31.3% stake, up from 30.2% previously, with roughly 29.5 million shares. That is nearly a third of the company in activist hands. Sherborne's stake has been broadly static in share count terms since at least late 2024, but the April amendment shows the percentage climbing as shares outstanding fell. As the disclosure caveat requires: these positions are as-last-disclosed around the 5% threshold, and a holder can fall below 5% without filing again, but at 31% that scenario is remote. The Vanguard Group, by contrast, exited entirely, filing a 0.0% position in March 2026 after holding 7.59% previously. That is a meaningful institutional departure. BlackRock added 237,745 shares in the most recent quarter to reach 13.8% of shares, providing a counterweight. Insider activity has been limited to grant and award transactions rather than open-market purchases, so there is no conviction signal from that direction.

ORTEX forecasts a 55% probability that NAVI is deleted from the CRSP US Small index at the December 2026 quarterly review. The rank date is December 4, with a potential trade date of December 22. The price that decides the outcome is $9.34: NAVI needs to close above that level to avoid the exit line, and at $8.98 it is currently 4% below it. The estimated forced selling flow if deletion is confirmed is $9 million, equivalent to roughly 0.8 days of normal volume. That is not a large mechanical overhang on its own, but it adds a directional weight to the stock at a moment when it is already drifting lower into earnings.

With the quarterly print seven days away, the focus narrows to whether credit metrics have stabilised after the NIM compression and NCO widening that dominated the bear case heading into 2026, and whether Sherborne's continued presence on the register produces any visible pressure on management direction.

Stocks in this article

See the live data behind this article on ORTEX.

Open NAVI on ORTEX →

How this article was generated

Generated
21 Oct 2026, 22:32
Data as of
21 Oct 2026, 22:31
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.